Singapore, May 7 -- Inocras Hong Kong, a subsidiary of Inocras Inc., headquartered in San Diego, USA (formerly Genome Insight, Inc.), a pioneer in whole-genome sequencing and analysis services for cancer and rare diseases, has announced the launch of the HRDetect programme, which provides free BRCA or HRD genetic testing to eligible cancer patients in Hong Kong and Macau.

This initiative is taking place in partnership with the Cancer Information Network Charitable Foundation (CICF) and with the generous sponsorship of AstraZeneca Hong Kong.

The programme will provide BRCA or HRD testing to eligible patients diagnosed with breast, ovarian, prostate and pancreatic cancer. Eligible patients also receive free pre- or post-test genetic couns...